Junior principal investigator @Merve_Kaya___ presents the design of the 🌈RAINBO MMRd-GREEN trial at #ASCO23 A phase III trial investigating the addition of durvalumab to pelvic RT in women with stage IB/II (with substantial LSVI) and stage III MMRd endometrial cancer

The TransPORTEC study that informed the design of the NSMP-ORANGE trial for women with high-risk NSMP endometrial cancer is out. Read the paper by Lisa Vermij et al. in Br J Cancer. rdcu.be/c30t3 @ProfEmmaCrosbie

The work of dr. Alicia Léon on the molecular classification of endometrial cancer changed the way we diagnose and treat this disease. She successfully defended her PhD thesis last week in Leiden, the Netherlands.

Two days ago Alicia Léon successfully defended her PhD thesis which was fundamental to the design of the RAINBO program and changed the way we diagnose and treat women with endometrial cancer today. Congratulations from the RAINBO research consortium!

Prof. Carien Creutzberg gives an excellent presentation on the endometrial cancer molecular classes and their application in the RAINBO program at #ESGO2022 in Berlin #CancerResearch

The RAINBO program is a platform of 4 international clinical trials on novel personalised therapies for women with endometrial cancer. Details on its design and current status are available at: clinicaltrials.gov/ct2/show/… #CancerResearch #wombcancer #clinicaltrials